INX IMCD N.V.

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

ROTTERDAM, The Netherlands (12 November 2024, 17:45 CET) – IMCD N.V. (“IMCD” or “Company”) announces its intention to raise approximately EUR 300 million of gross proceeds through an accelerated bookbuilding offering of new ordinary shares (the “New Shares”) in the share capital of the Company (the “Capital Raise”). The EUR 300 million Capital Raise will result in pro-forma leverage of 2.3. The pro-forma leverage is based on the adjusted leverage ratio as of 30 September 2024, reported in the Company's press release of 8 November 2024.

• The new shares to be issued represent c. 3.5% of IMCD N.V.’s issued share capital and shall be issued under the existing shareholder authorization granted at the Company’s 2024 AGM

• The Capital Raise will be a primary accelerated bookbuild offering

• This Capital Raise will provide IMCD increased financial flexibility as well as further strengthen its balance sheet

The Capital Raise will comprise: the issuance of New Shares for approximately EUR 300 million, representing approximately 3.5% of the total issued share capital, which will be offered through an accelerated bookbuilding process to institutional investors (the “Placing”). The New Shares will be issued on a non-pre-emptive basis under the existing mandate by the Company’s shareholders provided at the most recent AGM on 14 May 2024. The Placing is being made outside the United States, exclusively to institutional investors in the European Economic Area or the United Kingdom and to certain institutional investors in other jurisdictions, and in the United States in transactions pursuant to an exemption from, or in transactions not subject to, the registration requirements of the U.S. Securities Act of 1933, as amended (the “Securities Act”) to qualified institutional buyers (as defined in Rule 144A under the Securities Act).

No prospectus will be published in connection with the Placing.

Attached, the full press release in PDF format.

Attachment



EN
12/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMCD N.V.

 PRESS RELEASE

IMCD releases 2025 Annual Report

IMCD releases 2025 Annual Report Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today releases its 2025 Annual Report. The report offers the Company’s stakeholders a comprehensive view of IMCD’s performance in 2025. The full annual report is available in the of the Company’s website. Financial calendar:4 March 2026                Annual report 202530 April 2026                 First three months 2026 results30 April 2026                 Annual General Meeti...

 PRESS RELEASE

IMCD nominates Andreas Igerl as CCO and member of the Management Board

IMCD nominates Andreas Igerl as CCO and member of the Management Board Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Andreas Igerl to become Chief Commercial Officer (CCO) and member of the Management Board. Andreas Igerl, in his role as CCO, will strengthen the Management Board with his international experience and will further drive commercial excellence within IMCD. In addition, he will continue ...

 PRESS RELEASE

IMCD nominates Ruud Joosten as Supervisory Board member

IMCD nominates Ruud Joosten as Supervisory Board member Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Ruud Joosten as member of the Supervisory Board. Ruud Joosten is the CEO of Royal BAM Group NV since 2020 and is a non-executive board member at Altana AG since 2024. He started his career at Sigma Coatings (currently PPG) in 1988. He joined AkzoNobel in 1996 where he held several management roles a...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Peer Walmart 4Q25/26 results. Arcadis: Main topics 4Q25/FY25 conference call. ASM: 4Q25 preview, FY26 should be strong. Brunel: 4Q25 result beats and trends stabilise; DACH back to growth in 1Q26; additional cost savings announced and special dividend. Cofinimmo: Beat on bottom line, strong investment outlook for 2026. IMCD: Another step in EMEA. Magnum Ice Cream Company: Peer Danone 4Q25 results. Recticel: Peer Kingspan FY25 results. Software sector: Cheaper code...

 PRESS RELEASE

IMCD to acquire Willows Ingredients to strengthen its food & nutrition...

IMCD to acquire Willows Ingredients to strengthen its food & nutrition offering throughout Ireland and the UK The acquisition will enhance IMCD’s capabilities in specialised health, sports and animal nutrition Rotterdam, the Netherlands (20 February 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces it has signed an agreement to acquire 100% of the shares in Willows Ingredients Group Limited (Willows Ingredients), a distributor of ingredients serving the food and nutrition sector...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch